Preventative speciality can diagnose rare and inherited health conditions but difficulty accessing the service is affecting ...
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival. The once-popular DNA-testing site will also halt work on therapies it ...
Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled precision medicine solutions ...